NABIS’ Post

The VentureCap Insights Newsletter (29 Aug 2023) - covering latest updates on fundraising, valuations, and revenue for startups raising or filing financials. Click below to read the full newsletter. You can also subscribe to the daily VentureCap Insights newsletter: https://lnkd.in/g_PfACy If you are a platform that would like to connect with a Startup or a VC, drop us an email at support@venturecapinsights.com and we can help you get that coverage, with our newsletters going out to nearly 30,000 readers - consisting of mostly startups and investors. #VentureCapInsights #Startups #Investors #VentureCapital #PrivateEquity #FinancialData

How do VCs weigh the impact of GLP-1 drugs? Today, I encourage you to join Ludwig Pierre Schulze, Meera Oak, Naren Ramaswamy, Alim Giga, and Grant Demeter for a compelling discussion on the downstream economic effects of GLP-1 adoption in drugs like Ozempic®, and the potential of early-stage ventures in this field.

Venture Capital News - Venture Capital News Headlines

The Big VC Con Game Our large, growing cannabis sector is attracting the attention of many Venture Capital (VC) funds. This interest will accelerate once interest rates decline and funds look to deploy their ‘dry powder’’ (i.e. investment capital) currently sitting in bank accounts. Moreover, the passing of SAFER and Rescheduling will provide further impetus to jumping into cannabis. Cannabis leaders, however, should understand how venture capital works before embracing them as funding partners. A VC’s modus operandi is not necessarily a good fit with CapEx hungry, naive cannabis firms.  Here’s why: 1. A Potemkin Village Many self-proclaimed VCs are not true VCs who have kickstarted world-class firms.  They might have a pool of capital but lack investment experience, connections and knowledge of the weed industry.  Dealing with these tire-kicking , knowledge-starved VCs can be a long, frustrating and ultimately unsuccessful exercise. 2. Long odds Few companies secure VC funding because (with some exceptions) cannabis fundamentals do not match their deal criteria.  Unlike tech or life sciences, there is little patentable IP or sustainable competitive advantage to invest behind. And margins are low compared to other investable sectors.  Your business could still be funded but it would have to stand out from the crowd, which is very tough. Most financings are with founders with previous exits, close connections or are tag along investments with other canna-experienced funders.  Cannabis leaders are often not plugged into these networks.  3. Valuation games   VCs need to show big investment returns to their limited partners - and to justify their management fees. To do this, VCs play a valuation game. Their investment secures a boatload of penny (or sub-penny) shares at low valuations.  Later funding rounds at higher share prices (i.e. paper valuation increases) display their investing prowess.  They then count on a future sale or IPO in a frothy equity market to harvest their cash.  Predictably, the VC’s are incentivized to find an operator (i.e. a sucker) where they can cut themselves a really sweet valuation deal with advantageous liquidity terms.  Inevitably, the investee will get hammered on valuation, terms and their cap table, and potentially be hamstrung strategically.  If you doubt me, check out the psychedelics industry. To be fair, not all VCs meet the above description.  Nevertheless, leaders need to be mindful of the challenges with this funding channel. Smart and honest cannabis VCs will seek out what matters today – profit and free cash flow.  Get that. Have leverage.    Subscribe to my free newsletter (link in comments), the Cannabis Management Review, for more unique content. If you don’t want to miss my unique content delivered bi-weekly into your feed go to my profile and click the bell icon on the top right.  Pick Select, All new Posts #venturecapital #funding #cannabisindustry #cannabis #vc #venturefunding

Will investment 💰 start flowing again in 2024? .......leaders who attended Benzinga's Cannabis Capital Conference this week?? VC and private equity money has been hard to come by in just about any industry in the past year and half. Cannabis, even harder! But, funds start to get itchy feet after a stretch. That money is there, and can't sit around doing nothing. After all, funds exist to make investments. Still, with all of the bad investments made in cannabis over the years and stock prices remaining low, we can assume that investors will be more savy this time around. Privately held brands with positive cash flow and loads of runway are likely to be the best bet. But what other sectors of cannabis will likely get funded this year? #cannabis #thc #hemp #investment #benzinga #capital #startups

TechCrunch+ Roundup: Traction slide help, climate tech homework, Euro cannabis investor survey - https://lnkd.in/gAr7K_js - - New Post Shared by www.shipwr3ck.com - - A killer traction slide needs as much favorable customer and market data as you can gather, such as recurring revenue, customer acquisition cost and conversion rates. It’s your first opportunity to show off and build investor confidence simultaneously. But what if you don’t have any wins to boast about yet? For pre-revenue startups, Haje Jan Kamps says the traction slide should “describe the risk you’ve designed out of the business,” such as regulatory uncertainty. Full TechCrunch+ articles are only available to members Use discount code TCPLUSROUNDUP to save 20% off a one- or two-year subscription “To figure out what investors are most scared about, talk to them and pay attention to the questions they ask,” he writes. “You can then design an experiment around that and report your findings as traction.” Thanks very much for reading, Walter Thompson Editorial Manager, TechCrunch+ yourprotagonist What to do about your traction slide when you don’t have revenue yet Get the TechCrunch+ Roundup newsletter in your inbox! To receive the TechCrunch+ Roundup as an email each Tuesday and Friday, scroll down to find the “sign up for newsletters” section on this page, select “TechCrunch+ Roundup,” enter your email, and click subscribe Click here to subscribe 5 key questions climate tech founders should ask impact investors Image Credits: Jake Lomachevsky - opens in a new window - / Getty Images Globally, companies that are trying to solve environmental and social problems are worth more than $2.3 trillion, according to a study by Dealroom.co. The entrepreneurs building in this sector have lofty aspirations, says Agnes Svensson, chief impact officer at Norrsken VC, but enthusiasm can only get you so far. “To help drive more trackable impact investments, here are five key questions that all founders should consider asking impact investors competing for a space on your cap table.” 5 key questions climate tech founders should ask impact investors Can Europe’s cannabis market avoid the US’ mistakes? Investors chime in Image Credits: Bryce Durbin / TechCrunch America’s medical and recreational cannabis market took off after decades of prohibition, but Anna Heim interviewed investors in Europe who are “wary of the mistakes they’ve seen being made in the U.S.” Now that German regulators recently “watered down its law reform plans,” she asked the group about how they’re advising portfolio companies, whether their approach to investing has shifted, and if they’re accepting cold pitches: Oliver Lamb, co-founder, Óskare Capital Emily Paxhia, co-founder and managing partner, Poseidon Investment Management Matt Hawkins, founder and managing partner, Entourage

𝗨𝗻𝗶𝘁𝗲𝗱 𝗩𝗲𝗻𝘁𝘂𝗿𝗲𝘀, 𝗜𝗻𝗦𝗶𝗹𝗶𝗰𝗼𝗧𝗿𝗶𝗮𝗹𝘀' 𝗸𝗲𝘆 𝗶𝗻𝘃𝗲𝘀𝘁𝗼𝗿, 𝗮𝗻𝗻𝗼𝘂𝗻𝗰𝗲𝘀 𝗳𝗶𝗿𝘀𝘁 𝗰𝗹𝗼𝘀𝗲 𝗼𝗳 𝗻𝗲𝘄 €𝟭𝟱𝟬𝗺 𝗳𝘂𝗻𝗱   United Ventures has successfully closed the first round of its new fund at €65m, targeting a total size of €150m. Over the next 5 years, the firm aims to back 15-18 early-stage European #tech companies, with a particular focus on the Italian ecosystem.   🇮🇹 With approximately 70% of their current portfolio companies being Italian, United Ventures sees untapped potential in the #Italianmarket. The firm has also celebrated successful exits from portfolio companies, indicating their strong track record.   As one of the companies within United Ventures' portfolio, we are very happy about this further expansion. Seeing the investment strategy that led to the support of our company acknowledged by the financial market backing the establishment of this new fund is truly remarkable. We strongly value our strategic partnership, as well as the opportunities it brings to drive #innovation and growth in #virtual #clinicaltrials and simulation-based #drugdevelopment to revolutionize both #healthcare and #pharmaceutical industries. ℹ https://lnkd.in/d39cknHf

San Diego is on a *HOT* streak with *COOL* companies across tech, consumer, and biotech. Top honors go to Shield AI (AI x Defense) with a $500M raise and three $2B+ M&A transactions (Thanks Bristol Myers Squibb, Sanofi, and Johnson & Johnson) in the lifesciences space !!! Check out the below article by Fred Grier for more details. #AIDecade

Investing in Cannabis Startups: How to Choose the Right Opportunities Looking to venture into the realm of investing in cannabis startups? Unravel the dynamic and rapidly evolving industry with our comprehensive analysis.  Cannabis startups can be extremely tricky, but also have very nice cash flows in certain situations.  States with limited cannabis licenses have the best potential for outsized returns. What are cannabis startups? Cannabis startups are young, emerging businesses focused on the cultivation, distribution, and retail of cannabis products and services. Their business structure often revolves around the research and development of novel cannabis-centric solutions to provide Intellectual Property beyond the coveted cannabis license. With a diverse range of offerings, these startups can delve into anything from new strains of cannabis, essential tools for growers, medical applications, to holistic consumer products and software https://lnkd.in/gvgrSCv8 #InvestinginCannabisStartups

Elevate Ventures 2023 Results are in! We are hyper-focused on three core activities: Community | Capital | Acceleration. Below is a high level snapshot on 2023 results as we continue to rank as the #1 most active VC in the Great Lakes Region and Top 20 in the world per Pitchbook League Tables. Community - Launched RALLY | 3,000+ innovators from 15 countries and 39 states - 36 statewide events - 45 GetIN podcasts Capital - 112 Deals | That's 1 Deal Every 2.32 Business Days - $21.7M Committed - $20,000 to $1M Investment Size - $172.1M Total Deployed in Market - $2.2B+ Co-investments - 12.81x Leverage Ratio - 34,809 (5,426 Direct Jobs | 29,383 Indirect Jobs) - $1,299.95 Cost Per Job Created Acceleration - 106 BOD seats - 45 Operating Partners - 12 Partner Programs ...and we are just getting started. In 2024, we are hyper focused on accelerating post investment value add for our portcos and launching Elevate 3.0. We can't wait to share what we have in store! Thank you to everyone statewide that makes this innovation ecosystem vibrant and a special thank you to our partners at the Indiana Economic Development Corporation! It is also an honor to be among the Top 9 newsmakers in 2023 by Indianapolis Business Journal along with Dave Ricks Eli Lilly and Company, Mung Chiang Purdue University, Sue Finkam City of Carmel, Joe Hogsett City of Indianapolis, Jim Irsay Indianapolis Colts, Jennifer Rumsey Cummins Inc., Jonathon Taylor Indianapolis Colts and Shawn Fain United Auto Workers.